Literature DB >> 24381417

Diagnostic Role of Tumour Markers CEA, CA15-3, CA19-9 and CA125 in Lung Cancer.

Indranath Ghosh1, Debojyoti Bhattacharjee2, Anjan Kumar Das3, Goutam Chakrabarti4, Anindya Dasgupta2, Subir Kumar Dey1.   

Abstract

The aim of this study was to assess the diagnostic yield of the tumour markers carcinoembryonic antigen, carbohydrate antigen 15-3, carbohydrate antigen 19-9 and carbohydrate antigen 125, in serum and bronchoalveolar lavage fluid in a group of patients with bronchogenic carcinoma. Serum and bronchoalveolar lavage fluid samples were collected in a group of 90 patients with benign or malignant pulmonary diseases. After appropriate processing, tumour markers were determined by enzyme immunoassay. The diagnostic yields (sensitivity, specificity and predictive values) in each environment (serum and bronchoalveolar lavage fluid) were obtained by using "Receivers operating characteristic" curve. Determined individually, carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125, showed the greatest diagnostic accuracy in bronchoalveolar lavage fluid. Carbohydrate antigen 15-3 did so in serum. Carcinoembryonic antigen was the most relevant marker in bronchoalveolar lavage fluid. For the factors evaluated in this study, determination of carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125 in bronchoalveolar lavage fluid were clinically more useful markers in comparison with serum, although the latter may also be helpful in certain situations. Although there is no specific tumour marker for lung cancer, the combination of several can be used to diagnose most patients with lung cancer and also to rule out false positive and negative cases.

Entities:  

Keywords:  Bronchoalveolar lavage fluid; Lung carcinoma; Serum; Tumour markers

Year:  2012        PMID: 24381417      PMCID: PMC3547445          DOI: 10.1007/s12291-012-0257-0

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  23 in total

Review 1.  Early diagnosis of lung cancer.

Authors:  S Lam; H Shibuya
Journal:  Clin Chest Med       Date:  1999-03       Impact factor: 2.878

2.  CEA is an independent prognostic indicator that is associated with reduced survival and liver metastases in SCLC.

Authors:  Xueqin Yang; Dong Wang; Zhenzhou Yang; Yi Qing; Zhimin Zhang; Ge Wang; Zhixiang Yang; Zhengbo Wang
Journal:  Cell Biochem Biophys       Date:  2011-03       Impact factor: 2.194

3.  Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer.

Authors:  Yue Chen; Hao Zhang; Anjian Xu; Na Li; Jifu Liu; Chuanjun Liu; Dongxia Lv; Shanshan Wu; Lingyun Huang; Shuanying Yang; Dacheng He; Xueyuan Xiao
Journal:  Lung Cancer       Date:  2006-08-04       Impact factor: 5.705

4.  Tumour markers in serum, bronchoalveolar lavage and biopsy cytosol in lung carcinoma: what environment lends the optimum diagnostic yield?

Authors:  T C Pina; I T Zapata; F C Hernández; J B López; P P Paricio; P M Hernández
Journal:  Clin Chim Acta       Date:  2001-03       Impact factor: 3.786

5.  Clinical evaluation of pulmonary nodules with single-exposure dual-energy subtraction chest radiography with an iterative noise-reduction algorithm.

Authors:  S Kido; J Ikezoe; H Naito; J Arisawa; S Tamura; T Kozuka; W Ito; K Shimura; H Kato
Journal:  Radiology       Date:  1995-02       Impact factor: 11.105

Review 6.  [Tumor markers in lung cancer].

Authors:  S Niho; T Shinkai
Journal:  Gan To Kagaku Ryoho       Date:  2001-12

7.  Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature.

Authors:  David Shitrit; Boris Zingerman; Ariella Bar-Gil Shitrit; Dekel Shlomi; Mordechai R Kramer
Journal:  Oncologist       Date:  2005-08

Review 8.  Biomarkers for the lung cancer diagnosis and their advances in proteomics.

Authors:  Hye-Jin Sung; Je-Yoel Cho
Journal:  BMB Rep       Date:  2008-09-30       Impact factor: 4.778

9.  Effect of age and cigarette smoking on carcinoembryonic antigen levels.

Authors:  J C Alexander; N A Silverman; P B Chretien
Journal:  JAMA       Date:  1976-05-03       Impact factor: 56.272

10.  CEA levels in serum and BAL in patients suffering from lung cancer: correlation with individuals presenting benign lung lesions and healthy volunteers.

Authors:  Konstantinos Charalabopoulos; Agathi Karakosta; George Bablekos; Christos Golias; Alexandros Charalabopoulos; Eleni Tsanou; Dimitrios Peschos; Leonidas Zoganas; Anna Batistatou
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

View more
  14 in total

Review 1.  Identifying lung cancer in patients with active pulmonary tuberculosis.

Authors:  Cassandra S Parker; Carrie G Siracuse; Virginia R Litle
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

2.  Diagnostic value of epidermal growth factor, cancer antigen 125, and cancer antigen 15-3 in bronchoalveolar lavage fluid of lung cancer.

Authors:  S Sun; Z Chen; C Cao; B Wu; B Wang; Y Yu; Z Chen; Z Hu; Z Deng
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

3.  Evaluating the expression and diagnostic value of human epididymis protein 4 (HE4) in small cell lung cancer.

Authors:  Ximing Wang; Yahong Fan; Jinliang Wang; Huaming Wang; Wenchao Liu
Journal:  Tumour Biol       Date:  2014-04-15

4.  Diagnostic Difficulties in Woman with Crohn's Disease, Ascites, and Elevated Value of Serum CA125 Antigen.

Authors:  Maria Kłopocka; Ariel Liebert; Joanna Bielińska; Marcin Manerowski
Journal:  Case Rep Med       Date:  2014-11-23

5.  Diagnostic Value of Neuron-Specific Enolase (NSE) and Cancer Antigen 15-3 (CA 15-3) in the Diagnosis of Pleural Effusions

Authors:  Mohammad Ali Saba; Toraj Valeh; Hasan Ehteram; Hamed Haddad Kashani; Mahdiyeh Ghazi Zahedi
Journal:  Asian Pac J Cancer Prev       Date:  2017-01-01

6.  Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer.

Authors:  Yingji Jin; Seung Cheol Kim; Hyoung Jin Kim; Woong Ju; Yun Hwan Kim; Hong-Jin Kim
Journal:  Oncotarget       Date:  2017-11-01

7.  A nanobody targeting carcinoembryonic antigen as a promising molecular probe for non-small cell lung cancer.

Authors:  Hao Wang; Ai-Min Meng; Sheng-Hua Li; Xiao-Liang Zhou
Journal:  Mol Med Rep       Date:  2017-06-01       Impact factor: 2.952

8.  Study of lung cancer regulatory network that involves erbB4 and tumor marker gene.

Authors:  Xuhui Ma; Lu Li; Tongde Tian; Huaimin Liu; Qiujian Li; Qilong Gao
Journal:  Saudi J Biol Sci       Date:  2017-01-27       Impact factor: 4.219

9.  CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma.

Authors:  Sofi Isaksson; Per Jönsson; Nastaran Monsef; Hans Brunnström; Pär-Ola Bendahl; Mats Jönsson; Johan Staaf; Maria Planck
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

10.  Diagnostic efficacy of broncho-alveolar lavage carcino-embronic antigen in carcinoma of lung.

Authors:  Sudarsan Pothal; Kamlesh P Patil; Rekha Manjhi; Pravati Dutta
Journal:  J Family Med Prim Care       Date:  2019-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.